Application 021503
- Type
- NDA
- Sponsor
- AGOURON PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VIRACEPT | NELFINAVIR MESYLATE | TABLET;ORAL | EQ 625MG BASE | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 53808-0809 | Viracept | NELFINAVIR MESYLATE | State of Florida DOH Central Pharmacy | NDA | Current |
| 63010-027 | VIRACEPT | nelfinavir mesylate | AGOURON | NDA | Current |
| 63010-027 | VIRACEPT | nelfinavir mesylate | AGOURON | NDA | Current |
| 63010-027 | VIRACEPT | nelfinavir mesylate | AGOURON | NDA | Current |
| 63010-027 | VIRACEPT | nelfinavir mesylate | AGOURON | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 66880 | SUPPL | 2021-03-25 |
| 66874 | SUPPL | 2021-03-25 |
| 45359 | SUPPL | 2016-09-22 |
| 45302 | SUPPL | 2016-09-20 |
| 15622 | SUPPL | 2015-04-07 |
| 27949 | SUPPL | 2015-03-31 |
| 15621 | SUPPL | 2013-06-04 |
| 27948 | SUPPL | 2013-05-31 |
| 27947 | SUPPL | 2012-04-11 |
| 37084 | SUPPL | 2012-04-09 |
| 5564 | SUPPL | 2012-02-27 |
| 15620 | SUPPL | 2012-02-24 |
| 15619 | SUPPL | 2011-03-04 |
| 27946 | SUPPL | 2011-02-28 |
| 37083 | SUPPL | 2010-05-03 |
| 15618 | SUPPL | 2010-05-03 |
| 27945 | SUPPL | 2010-04-28 |
| 5563 | SUPPL | 2010-04-28 |
| 5562 | SUPPL | 2008-11-26 |
| 27944 | SUPPL | 2008-02-14 |
| 15617 | SUPPL | 2008-02-14 |
| 21702 | SUPPL | 2007-08-06 |
| 21701 | SUPPL | 2007-08-06 |
| 15616 | SUPPL | 2007-08-02 |
| 27943 | SUPPL | 2007-01-08 |
| 37082 | SUPPL | 2006-12-28 |
| 21700 | ORIG | 2005-12-16 |
| 5561 | SUPPL | 2005-10-20 |
| 15615 | SUPPL | 2005-09-30 |
| 15614 | SUPPL | 2004-06-07 |
| 5560 | SUPPL | 2004-06-07 |
| 15612 | SUPPL | 2004-04-05 |
| 27941 | SUPPL | 2004-03-24 |
| 27942 | SUPPL | 2003-08-29 |
| 15613 | SUPPL | 2003-08-28 |
| 5559 | ORIG | 2003-05-29 |
| 15611 | ORIG | 2003-05-06 |